REVS Columbia Research Enhanced Value ETF

Columbia Research Enhanced Value ETF (REVS) currently reports 306 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is XOM (3.91%), PG (3.49%), WFC (3.44%), with XOM as the largest single weight at 3.91%. Together, the top three holdings account for 10.84%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

From a capital efficiency perspective, ROIC is 15.66%, WACC is 7.32%, and the economic spread is 8.34%. On balance, holdings marginally exceed their cost of capital, suggesting modest but present value creation. Supporting metrics show ROE at 18.76% and ROA at 7.19%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Multiple analysis puts the portfolio at trailing P/E of 18.83, forward P/E of 14.28, PEG of 2.05. Trailing and forward multiples are nearly identical, indicating the market is pricing the portfolio on a relatively static earnings assumption. On a PEG basis, valuation is in the middle ground — fair for the growth on offer, with the return case resting on earnings delivery rather than re-rating. At 2.09, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined valuation and liquidity profile points to a portfolio where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

On the margin front: gross margin sits at 47.72%, operating margin at 23.10%, and free cash flow margin at 17.23%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

On the forward picture: TTM revenue growth of 7.70% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 31.9% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The composite picture leans positive, with capital efficiency and growth momentum providing the core of the investment thesis.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.